Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -44.9292.58-57.38-14.14442.89

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is -44.92 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14
Mar2021442.89

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14
Negative
Mar2021 442.89 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹923.1 Cr -1.1% 2.2% -28% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,791.0 Cr 1.2% 4.2% -10.9% Stock Analytics
DIVIS LABORATORIES ₹174,885.0 Cr -0.5% 8.9% 10.8% Stock Analytics
CIPLA ₹127,930.0 Cr 0.4% 3.7% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,108.0 Cr -0% -2.1% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,164.0 Cr 2.2% -1.8% -4.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-1.1%

2.2%

-28%

SENSEX

0.9%

2.5%

3.7%


You may also like the below Video Courses